University of Pennsylvania researchers tweaked an AI tutor to tailor the difficulty of practice problems for each student.

Executives are increasingly enamored with the promise of an AI-driven transformation and have invested accordingly. Most large-scale companies have initiated hundreds of pilots and provided widespread ...

Some readers may solve the problem procedurally: line up the two numbers, add the ones column, carry the one, and add the tens to get 43. Others might instead notice a creative shortcut: 29 + 14 is ...

FORTUNATELY, NOBODY WAS INJURED. CONTROLLING THE PYTHON POPULATION HERE IN FLORIDA, GOVERNOR DESANTIS SPOKE IN STUART TODAY ABOUT SOME NEW ACTIONS THE STATE PLANS TO TAKE TO CONTROL THE GROWTH OF ...

What are the most pressing global crises in 2026? Each year, the International Rescue Committee’s (IRC) Emergency Watchlist identifies the countries at greatest risk of new or worsening humanitarian ...

Five years ago, mathematicians Dawei Chen and Quentin Gendron were trying to untangle a difficult area of algebraic geometry involving differentials, elements of calculus used to measure distance ...

Microsoft’s MSFT-0.46%decrease; red down pointing triangle Copilot chatbot has become central to its artificial-intelligence strategy as the company’s close partnership with OpenAI diminishes. But the ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Smart home devices or apps acting up? I've been there: Here's what I do to get things working right. Tyler has worked on, lived with and tested all types of smart home and security technology for over ...

Recursion said REC-4881 was identified by an AI system that screened thousands of compounds. REC-4881 was initially evaluated for solid tumors, but is now the first inhibitor of its kind studied ...